These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 16673698)

  • 1. [Recurring depression].
    Lôo H
    Encephale; 2005 Oct; 31 Pt 2():S19-21. PubMed ID: 16673698
    [No Abstract]   [Full Text] [Related]  

  • 2. Depression and psoriasis comorbidity. Treatment with paroxetine: two case reports.
    Luis Blay S
    Ann Clin Psychiatry; 2006; 18(4):271-2. PubMed ID: 17162628
    [No Abstract]   [Full Text] [Related]  

  • 3. The modern pharmacopoeia: a return to depressive realism?
    Goldberg JF
    Bipolar Disord; 2008 Dec; 10(8):969-72. PubMed ID: 19594511
    [No Abstract]   [Full Text] [Related]  

  • 4. High CSF Tau-protein concentration in delirium induced by high dose psychiatric medication.
    Windhagen A; Wurster U; Kropp S; Ziegenbein M
    Aust N Z J Psychiatry; 2006; 40(11-12):1039-41. PubMed ID: 17054574
    [No Abstract]   [Full Text] [Related]  

  • 5. Using psychostimulants for treating residual symptoms in major depression.
    Berlim MT; Turecki MG
    J Psychiatry Neurosci; 2007 Jul; 32(4):304. PubMed ID: 17653297
    [No Abstract]   [Full Text] [Related]  

  • 6. Putting theory into practice: a challenging case study in the treatment of depression.
    J Fam Pract; 2003 Dec; Suppl():S63-70. PubMed ID: 14693080
    [No Abstract]   [Full Text] [Related]  

  • 7. Should adjunctive antipsychotic treatment be continued in remitted patients with depression?
    Uchida H; Suzuki T; Watanabe K; Kashima H
    Psychiatry Clin Neurosci; 2009 Feb; 63(1):126. PubMed ID: 19154222
    [No Abstract]   [Full Text] [Related]  

  • 8. Cognitive predictors of treatment response to bupropion and cognitive effects of bupropion in patients with major depressive disorder.
    Herrera-Guzmán I; Gudayol-Ferré E; Lira-Mandujano J; Herrera-Abarca J; Herrera-Guzmán D; Montoya-Pérez K; Guardia-Olmos J
    Psychiatry Res; 2008 Jul; 160(1):72-82. PubMed ID: 18501971
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A prospective study of escitalopram in the treatment of major depressive episodes in the presence or absence of anxiety.
    Olié JP; Tonnoir B; Ménard F; Galinowski A
    Depress Anxiety; 2007; 24(5):318-24. PubMed ID: 17041922
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combination of clozapine and maprotiline in refractory psychotic depression.
    Hrdlicka M
    Eur Psychiatry; 2002 Dec; 17(8):484. PubMed ID: 12504267
    [No Abstract]   [Full Text] [Related]  

  • 11. [Treatment of involutional depression with maprotiline].
    Molcan J; Novotný V; Nábĕlek L
    Act Nerv Super (Praha); 1982 May; 24(2):77-80. PubMed ID: 7102228
    [No Abstract]   [Full Text] [Related]  

  • 12. Seven cases of late-life depression treated with cilostazol-augmented therapy.
    Baba H; Kubota Y; Suzuki T; Arai H
    J Clin Psychopharmacol; 2007 Dec; 27(6):727-8. PubMed ID: 18004154
    [No Abstract]   [Full Text] [Related]  

  • 13. Multiple pulmonary thromboembolism and severe depression.
    Ferentinos P; Rizos E; Christodoulou C; Nikolaidou P; Chatzilia D; Loukides S; Papiris S; Lykouras L
    Gen Hosp Psychiatry; 2010; 32(5):560.e5-7. PubMed ID: 20851284
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mirtazapine-induced manic switch in adolescent unipolar depression.
    Goyal N; Sinha VK
    Aust N Z J Psychiatry; 2008 Dec; 42(12):1070-1. PubMed ID: 19031640
    [No Abstract]   [Full Text] [Related]  

  • 15. [Psychomotor retardation in depression assessed by visuomotor tasks. Overview and achievements of ten years' research].
    Pier MP; Hulstijn W; van Hoof JJ; Sabbe BG
    Tijdschr Psychiatr; 2006; 48(2):95-106. PubMed ID: 16958193
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hopelessness as a predictor of non-response to fluoxetine in major depressive disorder.
    Papakostas GI; Petersen T; Homberger CH; Green CH; Smith J; Alpert JE; Fava M
    Ann Clin Psychiatry; 2007; 19(1):5-8. PubMed ID: 17453655
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Validation of the Depression and Somatic Symptoms Scale by comparison with the Short Form 36 scale among psychiatric outpatients with major depressive disorder.
    Hung CI; Wang SJ; Liu CY
    Depress Anxiety; 2009; 26(6):583-91. PubMed ID: 19242983
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dysfunctional attitudes and perceived stress predict depressive symptoms severity following antidepressant treatment in patients with chronic depression.
    Pedrelli P; Feldman GC; Vorono S; Fava M; Petersen T
    Psychiatry Res; 2008 Dec; 161(3):302-8. PubMed ID: 18976817
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tardive dyskinesia associated with long-term administration of escitalopram and itopride in major depressive disorder.
    Park YM; Lee HJ; Kang SG; Choo CS; Cho JH
    Prog Neuropsychopharmacol Biol Psychiatry; 2009 Mar; 33(2):380-1. PubMed ID: 19121360
    [No Abstract]   [Full Text] [Related]  

  • 20. Escitalopram in the treatment of anxiety symptoms associated with depression.
    Bandelow B; Andersen HF; Dolberg OT
    Depress Anxiety; 2007; 24(1):53-61. PubMed ID: 16937393
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.